T. Rowe Price Associates’s Gentex GNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.36M Buy
199,419
+15,637
+9% +$363K ﹤0.01% 1470
2025
Q4
$4.28M Buy
183,782
+10,212
+6% +$246K ﹤0.01% 1443
2025
Q3
$4.91M Buy
173,570
+11,820
+7% +$314K ﹤0.01% 1395
2025
Q2
$3.56M Buy
161,750
+5,546
+4% +$121K ﹤0.01% 1399
2025
Q1
$3.64M Buy
156,204
+11,491
+8% +$294K ﹤0.01% 1357
2024
Q4
$4.16M Buy
144,713
+6,984
+5% +$209K ﹤0.01% 1334
2024
Q3
$4.09M Buy
137,729
+6,903
+5% +$214K ﹤0.01% 1362
2024
Q2
$4.41M Buy
130,826
+6,427
+5% +$222K ﹤0.01% 1257
2024
Q1
$4.5M Buy
124,399
+7,304
+6% +$253K ﹤0.01% 1242
2023
Q4
$3.83M Buy
117,095
+4,350
+4% +$134K ﹤0.01% 1290
2023
Q3
$3.67M Sell
112,745
-4,320
-4% -$138K ﹤0.01% 1254
2023
Q2
$3.43M Buy
117,065
+934
+0.8% +$25.7K ﹤0.01% 1301
2023
Q1
$3.26M Buy
116,131
+9,079
+8% +$256K ﹤0.01% 1300
2022
Q4
$2.92M Buy
107,052
+5,275
+5% +$141K ﹤0.01% 1337
2022
Q3
$2.43M Sell
101,777
-3,464
-3% -$95.1K ﹤0.01% 1382
2022
Q2
$2.94M Sell
105,241
-13,899
-12% -$404K ﹤0.01% 1513
2022
Q1
$3.48M Buy
119,140
+17,444
+17% +$542K ﹤0.01% 1541
2021
Q4
$3.54M Sell
101,696
-26,644
-21% -$945K ﹤0.01% 1553
2021
Q3
$4.23M Sell
128,340
-4,943
-4% -$160K ﹤0.01% 1535
2021
Q2
$4.41M Sell
133,283
-2,076
-2% -$72K ﹤0.01% 1526
2021
Q1
$4.83M Buy
135,359
+5,396
+4% +$192K ﹤0.01% 1473
2020
Q4
$4.41M Buy
129,963
+1,574
+1% +$48.5K ﹤0.01% 1460
2020
Q3
$3.31M Sell
128,389
-29,542
-19% -$785K ﹤0.01% 1456
2020
Q2
$4.07M Sell
157,931
-16,658
-10% -$417K ﹤0.01% 1407
2020
Q1
$3.87M Sell
174,589
-10,436
-6% -$290K ﹤0.01% 1373
2019
Q4
$5.36M Buy
185,025
+9,029
+5% +$254K ﹤0.01% 1388
2019
Q3
$4.85M Buy
175,996
+15,333
+10% +$405K ﹤0.01% 1382
2019
Q2
$3.95M Sell
160,663
-40
-0% -$906 ﹤0.01% 1423
2019
Q1
$3.32M Buy
160,703
+3,900
+2% +$81.5K ﹤0.01% 1463
2018
Q4
$3.17M Buy
156,803
+1,097
+0.7% +$23K ﹤0.01% 1459
2018
Q3
$3.34M Buy
155,706
+390
+0.3% +$9.02K ﹤0.01% 1510
2018
Q2
$3.58M Buy
155,316
+178
+0.1% +$4.22K ﹤0.01% 1482
2018
Q1
$3.57M Sell
155,138
-2,108
-1% -$48K ﹤0.01% 1470
2017
Q4
$3.29M Buy
157,246
+9,390
+6% +$187K ﹤0.01% 1484
2017
Q3
$2.93M Buy
147,856
+3,426
+2% +$62.3K ﹤0.01% 1508
2017
Q2
$2.74M Buy
144,430
+9,461
+7% +$184K ﹤0.01% 1497
2017
Q1
$2.88M Buy
134,969
+3,220
+2% +$67.6K ﹤0.01% 1498
2016
Q4
$2.59M Buy
131,749
+18
+0% +$328 ﹤0.01% 1515
2016
Q3
$2.31M Sell
131,731
-1,324,980
-91% -$22.9M ﹤0.01% 1517
2016
Q2
$22.5M Sell
1,456,711
-8,755
-0.6% -$139K ﹤0.01% 1059
2016
Q1
$23M Sell
1,465,466
-252,290
-15% -$3.67M ﹤0.01% 1030
2015
Q4
$27.5M Buy
1,717,756
+2,104
+0.1% +$34K 0.01% 986
2015
Q3
$26.6M Buy
1,715,652
+500
+0% +$7.95K 0.01% 991
2015
Q2
$28.2M Buy
1,715,152
+150
+0% +$2.62K 0.01% 1036
2015
Q1
$31.4M Sell
1,715,002
-83,340
-5% -$1.47M 0.01% 1001
2014
Q4
$32.5M Sell
1,798,342
-14,120
-0.8% -$235K 0.01% 987
2014
Q3
$24.3M Buy
1,812,462
+23,846
+1% +$347K 0.01% 1060
2014
Q2
$26M Buy
1,788,616
+6,516
+0.4% +$95.1K 0.01% 1046
2014
Q1
$28.1M Buy
1,782,100
+5,120
+0.3% +$81.7K 0.01% 1022
2013
Q4
$29.3M Sell
1,776,980
-55,940
-3% -$820K 0.01% 984
2013
Q3
$23.5M Sell
1,832,920
-239,000
-12% -$2.83M 0.01% 1037
2013
Q2
$23.9M Buy
+2,071,920
New +$23.3M 0.01% 1024

Other funds holding GNTX

T. Rowe Price Associates's GNTX Position: Q1 2026 in Review

T. Rowe Price Associates increased its Gentex (GNTX) stake by 8.5% in Q1 2026, buying an estimated $363K and bringing the position to 199,419 shares worth $4.36M. The position accounts for ﹤0.01% of the portfolio, ranked #1470.

T. Rowe Price Associates first reported a position in GNTX in Q2 2013 and has held it in 52 quarters since. The position peaked at $32.5M in Q4 2014. 502 funds tracked by Wall St. Rank hold GNTX as of Q1 2026.

  • T. Rowe Price Associates held 199,419 shares of Gentex worth $4.36M as of Q1 2026.
  • T. Rowe Price Associates bought 15,637 Gentex shares in Q1 2026, an estimated $363K.
  • Gentex made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #1470 holding.
  • T. Rowe Price Associates first reported a position in Gentex in Q2 2013 and has held it in 52 quarters since.
  • T. Rowe Price Associates's Gentex position peaked at $32.5M in Q4 2014.
  • 502 funds tracked by Wall St. Rank held Gentex as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.